Loading…
CML Patients Who Fail to Achieve ≤ 1% BCR::ABL1 at 12 Months or ≤ 0.1% BCR::ABL1 at 24 Months (major molecular response, MMR) Show Significantly Inferior Survival, but Not Due to CML-Related Deaths: Data from an Italian Real-Life Observational Study
Giai, Valentina, Rosso, Tiziana, Castagnetti, Fausto, Pregno, Patrizia, Bonifacio, Massimiliano, Capodanno, Isabella, Tiribelli, Mario, Stagno, Fabio, Caocci, Giovanni, Gozzini, Antonella, Luciano, Luigiana, Galimberti, Sara, Bocchia, Monica, Patriarca, Andrea, Lanzarone, Giuseppe, Martino, Bruno, Guella, Anna, Scortechini, Anna Rita, Fava, Carmen, Fozza, Claudio, Sica, Simona, Di Renzo, Nicola, Musto, Pellegrino, Pastore, Domenico, Maggi, Alessandro, Pizzuti, Michele, Melillo, Lorella Maria Antonia, Carella, Angelo Michele, Tarantini, Giuseppe, Mele, Anna, Calistri, Elisabetta, Coppi, Maria Rosaria, Saccona, Fabio, Scalzulli, Emilia, Battaglio, Beatrice, Iezza, Miriam, Bitetti, Cinzia, Freilone, Roberto, Rosti, Gianantonio, Albano, Francesco, Pane, Fabrizio, Specchia, Giorgina, Breccia, Massimo, Ciccone, Giovannino, Saglio, Giuseppe
Published in Blood (05.11.2024)
Published in Blood (05.11.2024)
Get full text
Journal Article
Loading…
Systematic Review of Normal Subjects Harbouring BCR-ABL1 Fusion Gene
Kuan, Jew Win, Su, Anselm Ting, Leong, Chooi Fun, Osato, Motomi, Sashida, Goro
Published in Acta haematologica (01.03.2020)
Published in Acta haematologica (01.03.2020)
Get more information
Journal Article
Loading…
Disposition of asciminib, a potent BCR-ABL1 tyrosine kinase inhibitor, in healthy male subjects
Tran, Phi, Hanna, Imad, Eggimann, Fabian Kurt, Schoepfer, Joseph, Ray, Tapan, Zhu, Bing, Wang, Lai, Priess, Petra, Tian, Xianbin, Hourcade-Potelleret, Florence, Einolf, Heidi J.
Published in Xenobiotica (01.02.2020)
Published in Xenobiotica (01.02.2020)
Get full text
Journal Article
Loading…
Phase-1 study of vamotinib (PF-114), a 3rd generation BCR::ABL1 tyrosine kinase-inhibitor, in chronic myeloid leukaemia
Turkina, Anna, Vinogradova, Olga, Lomaia, Elza, Shatokhina, Evgeniya, Shukhov, Oleg, Chelysheva, Ekaterina, Shikhbabaeva, Dzhariyat, Nemchenko, Irina, Petrova, Anna, Bykova, Anastasiya, Siordiya, Nadiya, Shuvaev, Vasily, Mikhailov, Ilya, Novikov, Fedor, Shulgina, Veronika, Hochhaus, Andreas, Ottmann, Oliver, Cortes, Jorge, Gale, Robert Peter, Chilov, Ghermes
Published in Annals of hematology (01.05.2025)
Published in Annals of hematology (01.05.2025)
Get full text
Journal Article
Loading…
Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib
Hanfstein, B., Lauseker, M., Hehlmann, R., Saussele, S., Erben, P., Dietz, C., Fabarius, A., Proetel, U., Schnittger, S., Haferlach, C., Krause, S. W., Schubert, J., Einsele, H., Hanel, M., Dengler, J., Falge, C., Kanz, L., Neubauer, A., Kneba, M., Stegelmann, F., Pfreundschuh, M., Waller, C. F., Spiekermann, K., Baerlocher, G. M., Pfirrmann, M., Hasford, J., Hofmann, W.-K., Hochhaus, A., Muller, M. C.
Published in Haematologica (Roma) (01.09.2014)
Published in Haematologica (Roma) (01.09.2014)
Get full text
Journal Article
Loading…
PF-114 in Patients Failing Prior Tyrosine Kinase-Inhibitor Therapy Including BCR::ABL1 T315I
Turkina, Anna G., Vinogradova, Olga, Lomaia, Elza, Shatokhina, Evgeniya, Shukhov, Oleg A., Zaritskey, Andrey, Chelysheva, Ekaterina Yu, Shikhbabaeva, Dzhariyat, Nemchenko, Irina, Petrova, Anna, Bykova, Anastasiya, Shuvaev, Vasily, Siordia, Nadia, Cortes, Jorge E., Gale, Robert Peter, Baccarani, Michele, Ottmann, Oliver, Mikhailov, Ilya, Novikov, Fedor, Shulgina, Veronika, Chilov, Ghermes
Published in Blood (05.11.2021)
Published in Blood (05.11.2021)
Get full text
Journal Article
Loading…
Loading…
Inhibition of calcineurin combined with dasatinib has direct and indirect anti‐leukemia effects against BCR‐ABL1+ leukemia
Gardner, Lori A., Klawitter, Jelena, Gregory, Mark A., Zaberezhnyy, Vadym, Baturin, Dmitry, Pollyea, Daniel A., Takebe, Naoko, Christians, Uwe, Gore, Lia, DeGregori, James, Porter, Christopher C.
Published in American journal of hematology (01.09.2014)
Published in American journal of hematology (01.09.2014)
Get full text
Journal Article
Loading…
Tgrx-678, a Novel Allosteric Inhibitor of BCR-ABL1, Demonstrates Preclinical Anti-Leukemia Activity, High Oral Bioavailability and Synergism with Ponatinib to Suppress the Highly Resistant Compound Mutations
Shi, Yanxia, Jiang, Qian, Li, Linxin, Jiang, Shuzhen, Yan, Tingting, Zheng, Cuifang, Ai, Yixin, Wang, Yihan
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Loading…
Loading…
BCR-ABL1 Doubling-Times and Halving-Times May Predict CML Response to Tyrosine Kinase Inhibitors
Pennisi, Maria Stella, Stella, Stefania, Vitale, Silvia Rita, Puma, Adriana, Di Gregorio, Sandra, Romano, Chiara, Tirrò, Elena, Massimino, Michele, Antolino, Agostino, Siragusa, Sergio, Mannina, Donato, Impera, Stefana, Musolino, Caterina, Mineo, Giuseppe, Martino, Bruno, Zammit, Valentina, Di Raimondo, Francesco, Manzella, Livia, Stagno, Fabio, Vigneri, Paolo
Published in Frontiers in oncology (13.08.2019)
Published in Frontiers in oncology (13.08.2019)
Get full text
Journal Article
Loading…
Influence of major BCR-ABL1 transcript subtype on outcome in patients with chronic myeloid leukemia in chronic phase treated frontline with nilotinib
Genthon, Alexis, Nicolini, Franck Emmanuel, Huguet, Françoise, Colin-Gil, Carole, Berger, Marc, Saugues, Sandrine, Janel, Alexandre, Hayette, Sandrine, Cohny-Makhoul, Pascale, Cadoux, Nadine, Cayuela, Jean-Michel, Campos, Lydia, Guyotat, Denis, Flandrin-Gresta, Pascale
Published in Oncotarget (30.06.2020)
Published in Oncotarget (30.06.2020)
Get full text
Journal Article
Loading…
Colorimetric assessment of BCR-ABL1 transcripts in clinical samples via gold nanoprobes
Vinhas, Raquel, Correia, Cláudia, Ribeiro, Patricia, Lourenço, Alexandra, Botelho de Sousa, Aida, Fernandes, Alexandra R., Baptista, Pedro V.
Published in Analytical and bioanalytical chemistry (01.07.2016)
Published in Analytical and bioanalytical chemistry (01.07.2016)
Get full text
Journal Article
Loading…
Imatinib Induced Thyroid Dysfunction in BCR::ABL1 Positive Chronic Myeloid Leukaemia Patients: Sokal Score as a Predictor
Ahmed, Ibrahim Oluwaseun, Asafa, Muritala Abiola, Adeagbo, Babatunde Ayodeji, Adesunkanmi, Omololu Olufunmilayo, Adedeji, Tewogbade Adeoye, Asaleye, Christianah Mopelola, Bolarinwa, Rahman Ayodele, Durosinmi, Muheez Alani
Published in Indian journal of hematology & blood transfusion (13.01.2025)
Published in Indian journal of hematology & blood transfusion (13.01.2025)
Get full text
Journal Article
Loading…
Phase 1 Trial of Vodobatinib, a Novel Oral BCR-ABL1 Tyrosine Kinase Inhibitor (TKI): Activity in CML Chronic Phase Patients Failing TKI Therapies Including Ponatinib
Cortes, Jorge E., Saikia, Tapan, Kim, Dong-Wook, Alvarado, Yesid, Nicolini, Franck E, Khattry, Navin, Rathnam, Krishnakumar, Apperley, Jane, Deininger, Michael W., de Lavallade, Hugues, Charbonnier, Aude, Granacher, Nikki, Gambacorti-Passerini, Carlo, Lucchesi, Alessandro, Mauro, Michael J., Verhoef, Gregor, Vandenberghe, Peter, Whiteley, Andrew R., Apte, Shashikant, Yao, Siu-Long, Kothekar, Mudgal, Sreenivasan, Jayasree, HV, Bimba, Chimote, Geetanjali
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Loading…
A coiled-coil mimetic intercepts BCR-ABL1 dimerization in native and kinase-mutant chronic myeloid leukemia
Woessner, D W, Eiring, A M, Bruno, B J, Zabriskie, M S, Reynolds, K R, Miller, G D, O'Hare, T, Deininger, M W, Lim, C S
Published in Leukemia (01.08.2015)
Published in Leukemia (01.08.2015)
Get full text
Journal Article
Loading…
Pre-Emptive Tyrosine Kinase-Inhibitor Intervention Based on BCR/ABL1 Monitoring in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia after Allo-HSCT: Two Independent Observational Cohort Study
Hui, Liu, Xuan, Li, Lin, Ren, Deng, Lan, Huang, Fen, Fan, Zhiping, Nie, Danian, Li, Xudong, Liang, Xinquan, Xu, Dan, Zhang, Yu, Xu, Na, Ye, Jieyu, Jin, Hua, Lin, Dongjun, MA, Liping, Sun, Jing, Huang, Xiaojun, Liu, Qifa
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Loading…
Monocyte subsets and their phenotypes during treatment with BCR‐ABL1 tyrosine kinase inhibitors for Philadelphia chromosome‐positive leukemia
Konuma, Takaaki, Kohara, Chisato, Watanabe, Eri, Mizukami, Motoko, Nagai, Etsuko, Tanoue, Susumu, Isobe, Masamichi, Jimbo, Koji, Kato, Seiko, Ohno, Nobuhiro, Takahashi, Satoshi, Tojo, Arinobu
Published in Hematological oncology (01.04.2018)
Published in Hematological oncology (01.04.2018)
Get full text
Journal Article
Loading…
Loading…
BCR/ABL1 Transcripts in Healthy Individuals: A Comparative Analysis Between First-Degree Relatives of Patients with Chronic Myelogenous Leukemia and Subjects without Antecedents of the Disease
Meza-Espinoza, Juan Pablo, Vásquez-Jiménez, Erika Alejandra, Barajas-Torres, Reyna Lucía, Magaña-Torres, María Teresa, González-García, Juan Ramón
Published in Annals of clinical and laboratory science (01.11.2019)
Get full text
Published in Annals of clinical and laboratory science (01.11.2019)
Journal Article